Hepatopulmonary syndrome secondary prevention: Difference between revisions
No edit summary |
No edit summary |
||
| Line 3: | Line 3: | ||
{{CMG}}; {{AE}} {{Soroush}} | {{CMG}}; {{AE}} {{Soroush}} | ||
==Overview== | ==Overview== | ||
Effective measures for the secondary prevention of hepatopulmonary syndrome include considering the diagnosis in every patient with liver disease which present with hypoxemia and shortness of breath, looking for diffusion defects in | Effective measures for the secondary prevention of hepatopulmonary syndrome include considering the diagnosis in every patient with [[Hepato-biliary diseases|liver disease]] which present with [[hypoxemia]] and [[Dyspnea|shortness of breath]], looking for diffusion defects in [[Arterial blood gas|arterial blood gas analysis]], and considering specific examinations such as [[Echocardiography|agitated saline contrast echocardiography]] in selected patients. | ||
==Secondary Prevention== | ==Secondary Prevention== | ||
Effective measures for the secondary prevention of hepatopulmonary syndrome include: | Effective measures for the secondary prevention of hepatopulmonary syndrome include: | ||
*Considering the diagnosis in every patient with liver disease which present with hypoxemia and shortness of breath | *Considering the diagnosis in every patient with [[Hepato-biliary diseases|liver disease]] which present with [[hypoxemia]] and [[Dyspnea|shortness of breath]] | ||
*Looking for diffusion defects in | *Looking for diffusion defects in [[Arterial blood gas|arterial blood gas analysis]] | ||
*Considering specific examinations such as agitated saline contrast echocardiography in selected patients | *Considering specific examinations such as [[Echocardiography|agitated saline contrast echocardiography]] in selected patients | ||
==References== | ==References== | ||
Revision as of 16:22, 7 August 2019
|
Hepatopulmonary syndrome Microchapters |
|
Differentiating Hepatopulmonary syndrome from other Diseases |
|---|
|
Diagnosis |
|
Treatment |
|
Case Studies |
|
Hepatopulmonary syndrome secondary prevention On the Web |
|
American Roentgen Ray Society Images of Hepatopulmonary syndrome secondary prevention |
|
Risk calculators and risk factors for Hepatopulmonary syndrome secondary prevention |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Soroush Seifirad, M.D.[2]
Overview
Effective measures for the secondary prevention of hepatopulmonary syndrome include considering the diagnosis in every patient with liver disease which present with hypoxemia and shortness of breath, looking for diffusion defects in arterial blood gas analysis, and considering specific examinations such as agitated saline contrast echocardiography in selected patients.
Secondary Prevention
Effective measures for the secondary prevention of hepatopulmonary syndrome include:
- Considering the diagnosis in every patient with liver disease which present with hypoxemia and shortness of breath
- Looking for diffusion defects in arterial blood gas analysis
- Considering specific examinations such as agitated saline contrast echocardiography in selected patients